Work

IBCL-552: Administering Tafasitamab, Lenalidomide, and Rituximab for Follicular Lymphoma: A Single-Institution Experience From the Phase 3 inMIND Study

Year: 2026

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)02709-6

Authors: Jessica Zhao, Heather Rasmussen, Christina Poh, Danielle Janiszewski, Haobo Ren, Michael Arbushites, Ajay K Gopal

Institutions: Fred Hutch Cancer Center, City Of Hope National Medical Center, City of Hope, Incyte (United States), University of Washington

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204699833

FWCI:

Cites:

Cited by:

Related to: 10